Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Gilmore

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Virology|September 12, 2024
Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2Mengrui Wang, Maria Valadez-Ingersoll, Thomas D Gilmore
BMC Molecular Biology|September 25, 2013
Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoterRyan C Thompson, Iosif Vardinogiannis, Thomas D Gilmore
Plos One|May 14, 2013
The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activityRyan C Thompson, Iosif Vardinogiannis, Thomas D Gilmore
Cancer Letters|December 2, 2009
Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8Michael R Garbati, Gökçen Alço, Thomas D Gilmore
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2015
Characterizing the DNA binding site specificity of NF-κB with protein-binding microarrays (PBMs)Trevor Siggers, Thomas D Gilmore, Brian Barron, et al.
Cancer Letters|December 14, 2011
Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosisAlan T Yeo, John A Porco, Thomas D Gilmore
Oncogene|October 10, 2003
Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cellsDaniel T Starczynowski, Joseph G Reynolds, Thomas D Gilmore
Development Genes and Evolution|January 15, 2013
A report from the second Nematostella vectensis research conferenceThomas D Gilmore, Ann M Tarrant, John R Finnerty
Cell Cycle (Georgetown, Tex.)|February 5, 2010
Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphomaThomas D Gilmore, Ryan C Thompson, Anthony C Faber
Oncogene|July 20, 2005
Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming abilityDaniel T Starczynowski, Joseph G Reynolds, Thomas D Gilmore
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Virology|September 12, 2024
Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2Mengrui Wang, Maria Valadez-Ingersoll, Thomas D Gilmore
BMC Molecular Biology|September 25, 2013
Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoterRyan C Thompson, Iosif Vardinogiannis, Thomas D Gilmore
Plos One|May 14, 2013
The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activityRyan C Thompson, Iosif Vardinogiannis, Thomas D Gilmore
Cancer Letters|December 2, 2009
Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8Michael R Garbati, Gökçen Alço, Thomas D Gilmore
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2015
Characterizing the DNA binding site specificity of NF-κB with protein-binding microarrays (PBMs)Trevor Siggers, Thomas D Gilmore, Brian Barron, et al.
Cancer Letters|December 14, 2011
Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosisAlan T Yeo, John A Porco, Thomas D Gilmore
Oncogene|October 10, 2003
Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cellsDaniel T Starczynowski, Joseph G Reynolds, Thomas D Gilmore
Development Genes and Evolution|January 15, 2013
A report from the second Nematostella vectensis research conferenceThomas D Gilmore, Ann M Tarrant, John R Finnerty
Cell Cycle (Georgetown, Tex.)|February 5, 2010
Cyclins D3 and E go hand in hand with Cdk4/6 in diffuse large B-cell lymphomaThomas D Gilmore, Ryan C Thompson, Anthony C Faber
Oncogene|July 20, 2005
Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming abilityDaniel T Starczynowski, Joseph G Reynolds, Thomas D Gilmore
Pageof 8